HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assessing the neurological outcome of traumatic acute subdural hematoma patients with and without primary decompressive craniectomies.

AbstractBACKGROUND:
We have investigated the impact of primary decompressive craniectomies on neurological outcomes after adjusting for other predictive variables.
METHOD:
We have collected data from trauma patients with acute subdural hematomas in a regional trauma center in Hong Kong over a 4-year period. Patient risk factors were investigated using logistic regression.
RESULTS:
Out of 464 patients with significant head injuries, 100 patients had acute subdural hematomas and were recruited for analysis. Forty-four percent of the patients achieved favorable neurological outcomes after 6 months. Favorable neurological outcomes at 1 year were related to age, pupil dilatation, and motor GCS scores at the time of admission. In the 34 patients who underwent evacuation of acute subdural hematomas, primary decompressive craniectomy was not associated with favorable neurological outcomes.
CONCLUSION:
Primary decompressive craniectomy failed to show benefit in terms of neurological outcomes and should be reserved for cases with uncontrolled intra-operative brain swelling.
AuthorsGeorge Kwok-Chu Wong, Yuk-Wah Hung, Charing Chong, Janice Yeung, Stephanie Chi-Ping Ng, Tim Rainer, Wai-Sang Poon
JournalActa neurochirurgica. Supplement (Acta Neurochir Suppl) Vol. 106 Pg. 235-7 ( 2010) ISSN: 0065-1419 [Print] Austria
PMID19812956 (Publication Type: Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Decompressive Craniectomy (methods)
  • Female
  • Hematoma, Subdural (physiopathology, surgery)
  • Hong Kong
  • Humans
  • Male
  • Middle Aged
  • Neurologic Examination
  • Outcome Assessment, Health Care
  • Predictive Value of Tests
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: